REFERENCES Schneider A et al, Autoinjectors for large-volume subcutaneous drug delivery: a review of current research and future directions
The problem has only become more complex with the skyrocketing use of glucagon-like peptide 1 class (GLP-1) drugs, such as Ozempic and Wegovy
Understanding these differences allows informed decision making based on individual circumstances, risk tolerance, and goals
Type 2 diabetes mellitus (T2DM) is one of the major subtypes of DM, and its pathogenesis is more complex, involving insulin resistance and insulin secretion dysfunction (Xourafa et al., 2024)
[3] [5] If you are participating in a clinical trial involving an investigational GLP-1 patch, you must contact your research team immediately for specific instructions if your patch becomes detached
Other Incretins Researchers transitioning from studies on Semaglutide or Liraglutide should note that Retatrutide is generally more sensitive than its predecessors